Deep Medicine Acquisition Corp.
DMAQ
NASDAQ Global Market2.96
USD
-5.43
- -
CIK
0001857086
ISIN
US2437331026
CUSIP
243733102
Return %
Stock
S&P500
1Y
-71.54
18.21
3Y
-69.95
64.38
5Y
-69.95
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Humphrey P. Polanen
- Full Time Employees
- 2
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 595 Madison Avenue New York City NY United States of America 10017
- IPO Date
- Dec 2, 2021
- CIK
- 0001857086
- Similar Companies
- Business
- Deep Medicine Acquisition Corp. is a special purpose acquisition company (SPAC) initially focused on targeting businesses in the healthcare industry, particularly those involved in artificial intelligence (AI) applications for medical imaging and diagnostics. The company went public with an upsized initial public offering of approximately $126.5 million and was founded to invest in high-growth healthcare technology firms. Headquartered in the United States, Deep Medicine Acquisition Corp. aims to acquire and merge with companies that leverage AI to improve clinical decision-making workflows and radiology capabilities. The core business activities of Deep Medicine Acquisition Corp. as a SPAC involved raising capital for mergers and acquisitions within healthcare technology. A major product/service milestone includes its business combination with TruGolf, Inc., a leading provider of indoor golf simulation technology, including golf simulators, software, and hardware. This acquisition marked a strategic shift from healthcare-focused targets to a broader technology-oriented company, reflecting an expansion of business scope. Following the merger, the combined entity is operating under the name TruGolf Holdings, Inc., and TruGolf’s Class A common stock trades on Nasdaq under the symbol “TRUG.” This transition occurred in early 2024 and significantly transformed the company's operational focus and market positioning. Recent major company changes include the execution and closing of the definitive merger agreement with TruGolf, Inc. on January 31, 2024, which was approved by stockholders in January 2024. This business combination facilitated TruGolf’s public listing and provided resources to accelerate its growth. The merger also included a filing of a registration statement on Form S-4 with the SEC, detailing the transaction and finalizing the combination process during 2023. This event represents a key strategic realignment and operational expansion beyond the original healthcare investment mandate. In summary, Deep Medicine Acquisition Corp. initially operated as a healthcare technology-focused SPAC founded to target AI-driven medical and radiology companies, with headquarters in the U.S. After its business combination with TruGolf, Inc., it transformed into a publicly traded company specializing in golf simulation hardware and software, reflecting a notable business expansion and shift in industry focus from healthcare technology to sports technology and entertainment. The company now offers TruGolf’s suite of advanced golf simulators and related technologies across its geographic markets through Nasdaq-listed TruGolf Holdings, Inc. This combination marks the latest major development in the company's corporate evolution.
TRUGOLF, INC. AND DEEP MEDICINE ACQUISITION CORP.
TRUGOLF, INC. AND NASDAQ-LISTED SPAC DEEP MEDICINE ACQUISITION CORP.
Deep Medicine Acquisition Corp. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with TruGolf, Inc.
Why Is Deep Medicine Acquisition (DMAQ) Stock Up 17% Today?